Antimicrobial Response, Inflammatory Response |
Antiviral response |
<0.001 |
Decreased |
-3.341 |
48 |
Inflammatory Response |
Immune response of cells |
<0.001 |
Decreased |
-2.725 |
84 |
Antimicrobial Response, Inflammatory Response |
Antimicrobial response |
<0.001 |
Decreased |
-3.107 |
56 |
Neurological Disease |
Progressive neurological disorder |
<0.001 |
Decreased |
-2.157 |
133 |
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease |
Urinary tract cancer |
<0.001 |
Decreased |
-2.236 |
240 |
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease |
Renal cancer |
<0.001 |
Decreased |
-2.236 |
150 |
Cell Death and Survival |
Cell death of lymphoma cell lines |
<0.001 |
Decreased |
-3.104 |
36 |
Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral Metabolism |
Synthesis of cholesterol |
<0.001 |
Decreased |
-2 |
18 |
Cell Death and Survival |
Apoptosis of lymphoma cell lines |
<0.001 |
Decreased |
-2.81 |
29 |
Cell Death and Survival |
Cell death of macrophage cancer cell lines |
<0.001 |
Decreased |
-2.735 |
11 |
Cell Death and Survival |
Cell death of connective tissue cells |
<0.001 |
Decreased |
-2.034 |
75 |
Cell-To-Cell Signalling and Interaction, Inflammatory Response |
Response of phagocytes |
0.002 |
Decreased |
-2.498 |
32 |
Cell-To-Cell Signalling and Interaction, Embryonic Development |
Response of embryonic cell lines |
0.002 |
Decreased |
-3.111 |
12 |
Cell-To-Cell Signalling and Interaction |
Response of myeloid cells |
0.003 |
Decreased |
-2.466 |
31 |
Cell-To-Cell Signalling and Interaction, Inflammatory Response |
Immune response of phagocytes |
0.003 |
Decreased |
-2.787 |
29 |
Embryonic Development, Organismal Development |
Development of body trunk |
<0.001 |
Increased |
3.647 |
153 |
Infectious Diseases |
Viral Infection |
<0.001 |
Increased |
3.15 |
220 |
Infectious Diseases |
Infection by RNA virus |
<0.001 |
Increased |
3.075 |
114 |
Cancer, Organismal Injury and Abnormalities |
Development of malignant tumour |
<0.001 |
Increased |
2.984 |
786 |
Infectious Diseases |
Infection of Mammalia |
0.001 |
Increased |
2.978 |
42 |
Cellular Movement |
Cell movement of melanoma cell lines |
0.002 |
Increased |
2.715 |
21 |
Infectious Diseases |
Replication of Herpesviridae |
<0.001 |
Increased |
2.449 |
15 |
Cancer, Organismal Injury and Abnormalities |
Incidence of tumour |
<0.001 |
Increased |
2.428 |
815 |
Infectious Diseases |
Infection of cells |
<0.001 |
Increased |
2.331 |
97 |
Cancer, Organismal Injury and Abnormalities |
Malignant solid tumour |
<0.001 |
Increased |
2.277 |
1292 |
Infectious Diseases |
Replication of Murine herpesvirus 4 |
0.003 |
Increased |
2.236 |
5 |
Cardiovascular System Development and Function, Embryonic Development, Organ Development, Organismal Development, Tissue Development |
Cardiogenesis |
<0.001 |
Increased |
2.198 |
79 |
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease |
Tumorigenesis of reproductive tract |
<0.001 |
Increased |
2.19 |
459 |
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease |
Female genital neoplasm |
<0.001 |
Increased |
2.19 |
459 |
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease |
Ovarian tumour |
<0.001 |
Increased |
2.19 |
205 |
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities |
Endocrine gland tumour |
<0.001 |
Increased |
2.183 |
1024 |
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities |
Digestive organ tumour |
<0.001 |
Increased |
2.161 |
1130 |
Cancer, Organismal Injury and Abnormalities |
Frequency of tumour |
<0.001 |
Increased |
2.152 |
801 |
Cancer, Haematological Disease, Organismal Injury and Abnormalities |
Hematologic cancer |
0.002 |
Increased |
2.088 |
329 |
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities |
Liver tumour |
<0.001 |
Increased |
2.017 |
556 |